Accessibility Menu
 
Genenta Science S.p.A. logo

Genenta Science S.p.A.

(NASDAQ) GNTA

Current Price$0.73
Market Cap$16.22M
Since IPO (2021)-94%
5 YearN/A
1 Year-83%
1 Month-3%

Genenta Science S.p.A. Financials at a Glance

Market Cap

$16.22M

Revenue (TTM)

$0.00

Net Income (TTM)

$15.41M

EPS (TTM)

$-0.37

P/E Ratio

-1.86

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.73

Volume

0

Open

$0.73

Previous Close

$0.73

Daily Range

$0.73 - $0.73

52-Week Range

$0.59 - $10.00

GNTA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genenta Science S.p.A.

Industry

Biotechnology

Employees

9

CEO

Pierluigi Paracchi

Headquarters

Milan, MI 20132, IT

GNTA Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-38%

Return on Capital

-21%

Return on Assets

-20%

Earnings Yield

-53.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$16.22M

Shares Outstanding

23.43M

Volume

0

Avg. Volume

86.56K

Financials (TTM)

Gross Profit

$26.97K

Operating Income

$6.34M

EBITDA

$6.32M

Operating Cash Flow

$6.87M

Capital Expenditure

$7.63K

Free Cash Flow

$6.88M

Cash & ST Invst.

$28.15M

Total Debt

$7.60M

Genenta Science S.p.A. Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$14.04K

+33.0%

Gross Margin

0.00%

N/A

Market Cap

$16.22M

N/A

Market Cap/Employee

$1.25M

N/A

Employees

13

N/A

Net Income

$2.68M

+44.1%

EBITDA

$3.18M

+34.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$20.55M

+9.4%

Accounts Receivable

$1.29M

-35.8%

Inventory

$0.00

N/A

Long Term Debt

$7.60M

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-19.60%

N/A

Return on Invested Capital

-21.33%

N/A

Free Cash Flow

$1.69M

-46535.6%

Operating Cash Flow

$1.69M

-46548.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
JUNSJupiter Neurosciences, Inc.
$0.40+3.33%
BRNSBarinthus Biotherapeutics plc
$0.64-2.41%
MDCXMedicus Pharma Ltd. Common Stock
$0.29+0.39%
SKYESkye Bioscience, Inc.
$0.87+5.65%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.18+0.01%
PLTRPalantir Technologies
$146.03+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$50.51+0.01%
IBITiShares Bitcoin Trust
$45.40+0.02%

Questions About GNTA

What is the current price of Genenta Science S.p.A.?

Genenta Science S.p.A. is trading at $0.73 per share.

What is the 52-week range for Genenta Science S.p.A.?

Over the past 52 weeks, Genenta Science S.p.A. has traded between $0.59 and $10.00.

How much debt does Genenta Science S.p.A. have?

As of the most recent reporting period, Genenta Science S.p.A. reported total debt of $8.93M.

How much cash does Genenta Science S.p.A. have on hand?

Genenta Science S.p.A. reported $6.49M in cash and cash equivalents in its most recent financial results.

What is Genenta Science S.p.A.’s dividend yield?

Genenta Science S.p.A. does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.